These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38156846)

  • 1. Cost-Effectiveness Analysis of Ultrasound Surveillance for Cholangiocarcinoma in an Endemic Area of Thailand.
    Laopachee P; Siripongsakun S; Sangmala P; Chanree P; Hiranrat P; Srisittimongkon S
    Asian Pac J Cancer Prev; 2023 Dec; 24(12):4117-4125. PubMed ID: 38156846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-Utility and Cost-Effectiveness Analysis of Spinal Cord Stimulation for Chronic Refractory Pain in the Context of Developing Country.
    Zinboonyahgoon N; Saengsomsuan N; Chaikittiporn N; Wangnamthip S; Kositamongkol C; Phisalprapa P
    Pain Physician; 2023 Jan; 26(1):69-79. PubMed ID: 36791296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic Evaluation of Direct Oral Anticoagulants Compared to Warfarin for Venous Thromboembolism in Thailand: A Cost-Utility Analysis.
    Niyomsri S; Nimworapan M; Wongcharoen W; Dilokthornsakul P
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36833871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound surveillance for cholangiocarcinoma in an endemic area: A prove of survival benefits.
    Siripongsakun S; Vidhyarkorn S; Charuswattanakul S; Mekraksakit P; Sungkasubun P; Yodkhunnathum N; Tangruangkiat S; Ritlumlert N; Sricharunrat T; Jaroenpatarapesaj S; Soonklang K; Kulthanmanusorn A; Auewarakul CU; Mahidol C
    J Gastroenterol Hepatol; 2018 Jul; 33(7):1383-1388. PubMed ID: 29247982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation and budget impact analysis of the surveillance program for hepatocellular carcinoma in Thai chronic hepatitis B patients.
    Sangmala P; Chaikledkaew U; Tanwandee T; Pongchareonsuk P
    Asian Pac J Cancer Prev; 2014; 15(20):8993-9004. PubMed ID: 25374242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
    Phisalprapa P; Supakankunti S; Chaiyakunapruk N
    J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-utility analysis of transcatheter aortic valve implantation versus surgery in severe aortic stenosis patients with intermediate surgical risk in Thailand.
    Permsuwan U; Yoodee V; Buddhari W; Wongpraparut N; Thonghong T; Cheewatanakornkul S; Meemook K; Sakiyalak P; Duangpakdee P; Yadee J
    J Geriatr Cardiol; 2022 Nov; 19(11):822-832. PubMed ID: 36561052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of pharmacist-participated warfarin therapy management in Thailand.
    Saokaew S; Permsuwan U; Chaiyakunapruk N; Nathisuwan S; Sukonthasarn A; Jeanpeerapong N
    Thromb Res; 2013 Oct; 132(4):437-43. PubMed ID: 24041634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness Analysis of Sacubitril-Valsartan Compared with Enalapril in Patients with Heart Failure with Reduced Ejection Fraction in Thailand.
    Krittayaphong R; Permsuwan U
    Am J Cardiovasc Drugs; 2018 Oct; 18(5):405-413. PubMed ID: 29926351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-utility analysis of an alcohol policy in Thailand: a case study of a random breath testing intervention.
    Vichitkunakorn P; Khampang R; Leelahavarong P; Nontarak J; Assanangkornchai S
    BMC Health Serv Res; 2024 Jun; 24(1):739. PubMed ID: 38886718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An updated cost-effectiveness analysis of pneumococcal conjugate vaccine among children in Thailand.
    Dilokthornsakul P; Kengkla K; Saokaew S; Permsuwan U; Techasaensiri C; Chotpitayasunondh T; Chaiyakunapruk N
    Vaccine; 2019 Jul; 37(32):4551-4560. PubMed ID: 31280944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Utility Analysis of First-Line Pemetrexed Plus Cisplatin in Non-Small Cell Lung Cancer in Thailand.
    Permsuwan U; Thongprasert S; Sirichanchuen B
    Value Health Reg Issues; 2020 May; 21():9-16. PubMed ID: 31634796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Utility Analysis of Transcatheter Aortic Valve Implantation versus Surgery in High-Risk Severe Aortic Stenosis Patients in Thailand.
    Permsuwan U; Yoodee V; Buddhari W; Wongpraparut N; Thonghong T; Cheewatanakornkul S; Meemook K; Sakiyalak P; Duangpakdee P; Yadee J
    Clinicoecon Outcomes Res; 2022; 14():487-498. PubMed ID: 35909499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lateral lumbar interbody fusion (LLIF) reduces total lifetime cost compared with posterior lumbar interbody fusion (PLIF) for single-level lumbar spinal fusion surgery: a cost-utility analysis in Thailand.
    Boonsirikamchai W; Phisalpapra P; Kositamongkol C; Korwutthikulrangsri E; Ruangchainikom M; Sutipornpalangkul W
    J Orthop Surg Res; 2023 Feb; 18(1):115. PubMed ID: 36797750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of ultrasonography screening for nonalcoholic fatty liver disease in metabolic syndrome patients.
    Phisalprapa P; Supakankunti S; Charatcharoenwitthaya P; Apisarnthanarak P; Charoensak A; Washirasaksiri C; Srivanichakorn W; Chaiyakunapruk N
    Medicine (Baltimore); 2017 Apr; 96(17):e6585. PubMed ID: 28445256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy versus sulfonylurea monotherapy for people with type 2 diabetes and chronic kidney disease in Thailand.
    Permsuwan U; Dilokthornsakul P; Thavorn K; Saokaew S; Chaiyakunapruk N
    J Med Econ; 2017 Feb; 20(2):171-181. PubMed ID: 27645706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cost-effectiveness analysis of national smoking cessation services among chronic obstructive pulmonary disease patients in Thailand.
    Prasitwarachot R; Thavorn K; Patikorn C; Wattanasirichaigoon S; Rungruanghiranya S; Thongphiew A; Chaiyakunapruk N
    J Med Econ; 2023; 26(1):1377-1385. PubMed ID: 37818930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand.
    Permsuwan U; Chaiyakunapruk N; Dilokthornsakul P; Thavorn K; Saokaew S
    Appl Health Econ Health Policy; 2016 Jun; 14(3):281-92. PubMed ID: 26961276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand.
    Leelahavarong P; Chaikledkaew U; Hongeng S; Kasemsup V; Lubell Y; Teerawattananon Y
    BMC Health Serv Res; 2010 Jul; 10():209. PubMed ID: 20633303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of rituximab and mycophenolate mofetil for neuromyelitis optica spectrum disorder in Thailand: Economic evaluation and budget impact analysis.
    Aungsumart S; Apiwattanakul M
    PLoS One; 2020; 15(2):e0229028. PubMed ID: 32050011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.